0001225208-19-002355.txt : 20190212
0001225208-19-002355.hdr.sgml : 20190212
20190212211515
ACCESSION NUMBER: 0001225208-19-002355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190208
FILED AS OF DATE: 20190212
DATE AS OF CHANGE: 20190212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wengel Kathryn E
CENTRAL INDEX KEY: 0001745955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 19593012
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2019-02-08
0000200406
JOHNSON & JOHNSON
JNJ
0001745955
Wengel Kathryn E
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, Chief GSC Officer
Common Stock
2019-02-08
4
M
0
5882.0000
0
A
40196.7975
D
Common Stock
2019-02-08
4
F
0
2373.0000
132.0000
D
37823.7975
D
Common Stock
2019-02-11
4
M
0
6722.0000
0
A
44545.7975
D
Common Stock
2019-02-11
4
A
0
1102.0000
0.0000
A
45647.7975
D
Common Stock
2019-02-11
4
F
0
4047.0000
131.9400
D
41600.7975
D
Common Stock
21.0000
I
By 401k
Common Stock
281.0000
I
By ESOP
Restricted Share Units
2019-02-08
4
M
0
5882.0000
0.0000
D
2019-02-08
Common Stock
5882.0000
0.0000
D
Employee Stock Options (Right to Buy)
131.9400
2019-02-11
4
A
0
38753.0000
0.0000
A
2022-02-11
2029-02-11
Common Stock
38753.0000
38753.0000
D
Performance Share Units
2019-02-11
4
M
0
6722.0000
0.0000
D
2019-02-08
Common Stock
6722.0000
0.0000
D
Restricted Share Units
2019-02-11
4
A
0
1896.0000
0.0000
A
2022-02-11
Common Stock
1896.0000
1896.0000
D
Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting.
Shares withheld for payment of taxes upon vesting of Restricted Share Units.
Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.
Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.
Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019).
Awarded under Issuer's Long-Term Incentive Plan.
Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
poawengel.txt
Linda E. King, as attorney-in-fact for Kathryn E. Wengel
2019-02-12
EX-24
2
poawengel.txt
POWER OF ATTORNEY
Executive Officers
Know all persons by these presents, that the undersigned hereby constitutes and
appoints each of Thomas J. Spellman III, Renee A. Brutus, Michelle R. Ryan,
Linda E. King and Maria A. Frucci, signing singly, as the undersigned's true and
lawful attorneys-in-fact to:
(1) complete and execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer of Johnson & Johnson (the
"Company"), Forms 3, 4 and 5 (including any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder (the "Exchange Act") and Form 144
in accordance with Rule 144 of the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder (the "Securities Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, 5 and
144 (including any amendments thereto) and timely file such form with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, (i) any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act or
(ii) any liability of the undersigned for failure to comply with such
requirements. The undersigned agrees that each such attorney-in-fact may rely
entirely on information furnished orally or in writing by or at the direction of
the undersigned to the attorney-in-fact.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date set forth below.
/s/ Kathryn E. Wengel
Name: Kathryn E. Wengel
Date: November 5, 2018